David G. Watumull

Hawaii Biotech, Inc. operates as a biotechnology company that focuses on the research and development of vaccines for established and emerging infectious diseases. It has developed proprietary expertise in the production of recombinant proteins applicable to the development of safe and effective vaccines. The firm's products include anti-toxin drugs for the lethal factor from B. anthracis and the botulinum toxin from C. botulinum. The company was founded in 1982 and is headquartered in Honolulu, HI.

Koffee Korner, Inc. engages in retailing of coffee. The company purchases and roasts high quality whole bean coffees that it sells, along with handcrafted coffee and tea beverages and a variety of fresh food items, through its retail store in Houston, Texas. It products include coffee, tea, ice cream shake and javaccino. The company was founded on July 7, 2003 and is headquartered in Washington Boro, PA.

Part of Cardax, Inc., Cardax Pharma, Inc. is a pharmaceutical company that previously focused on developing a platform of proprietary, exceptionally safe, small molecule compounds for large unmet medical needs where oxidative stress and inflammation play key causative roles. The private company is based in Honolulu, HI. The company may seek to monetize its pharmaceutical assets through licensing or sale. Astaxanthin use is supported by hundreds of peer-reviewed papers published in leading medical research journals. The company was founded by David G. Watumull, Samuel F. Lockwood, and David G. Watumull has been the CEO since incorporation. Cardax Pharma was acquired by Koffee Korner, Inc. on February 07, 2014 for $15 million.

Founded in 1979, First Honolulu Securities is a Honolulu-based broker/dealer and investment banker headquartered in Honolulu, Hawaii

Cardax Pharmaceuticals, Inc. develops proprietary small molecule therapies for large unmet medical needs. It develops proprietary small molecule therapies for large unmet needs where oxidative stress and inflammation play important causative roles-including cardiovascular disease, hepatitis, macular degeneration and many cancers. The company's proprietary, synthetic, natural compound derivatives represent a novel treatment approach that offers efficacy along with an outstanding safety profile, oral bioavailability and tissue selectivity. Cardax Pharmaceuticals was founded by David G. Watumull and Samuelf Lockwood in May 2006 and is headquartered in Honolulu, HI.

Hawaii Science & Technology Council is a non-profit organization that provides information and technical assistance. The private company is based in Honolulu, HI.